Celltrion
068270.KS
#724
Rank
C$39.25 B
Marketcap
$191.52
Share price
0.05%
Change (1 day)
-0.38%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Net assets

Net assets on the balance sheet as of September 2024 : C$18.68 Billion

According to Celltrion 's latest financial reports the company has C$18.68 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Celltrion - Net assets on balance sheet (from 2007 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$C$4.59 B6.03%
2021-12-31$C$4.33 B7.84%
2020-12-31$C$4.02 B23.97%
2019-12-31$C$3.24 B2.46%
2018-12-31$C$3.16 B11.4%
2017-12-31$C$2.84 B23.73%
2016-12-31$C$2.29 B14.33%
2015-12-31$C$2.00 B40.73%
2014-12-31$C$1.42 B30.09%
2013-12-31$C$1.09 B9.12%
2012-12-31$C$1.00 B27.46%
2011-12-31$C$0.78 B14.1%
2010-12-31$C$0.69 B164.88%
2009-12-31$C$0.26 B21.42%
2008-12-31$C$0.21 B651.06%
2007-12-31$C$28.63 M